IEEE

In-Silico Identification of Shared Hub-Genes Between Idiopathic Pulmonary Fibrosis and Tuberculosis Diseases & Drug Repurposing

Abstract: Idiopathic Pulmonary Fibrosis (IPF) and Tuberculosis (TB) are both complicated diseases and gradually increasing their incidence rates worldwide. Some population-based studies reported that ...

India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough

While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, ...

Long-term cure rates for multidrug-resistant tuberculosis much better than expected

A new national cohort study provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The ...
Medical Dialogues

Higher Rifampicin Doses Accelerate Bacterial Clearance in Pulmonary TB, But Safety Concerns Remain: ICMR

Enhanced Bacteriological Response: The study reveals that high-dose rifampicin increased the 8-week sputum conversion rate ...
Medscape

Improving Latent Tuberculosis Infection Identification and Treatment Adherence

While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises ...
European Medical Journal

Tuberculosis Vaccine Trial Shows Limited Overall Protection

A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary ...

Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)

BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and ethionamide), an innovative drug combination that overcomes ...